Immix Biopharma, Inc. Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.10M-0.18M-0.00M
Gross Profit -0.10M-0.18M-0.00M
Operating items
Research & Development 0.25M0.13M4.20M8.74M11.29M
Selling, General & Administrative 0.21M1.23M4.02M7.41M11.38M
Operating Expenses 0.45M1.35M8.22M16.14M22.67M
Operating Income -0.45M-5.12M-8.22M-16.14M-22.67M
EBIT -0.45M-5.12M-8.22M-16.14M-22.67M
Non-operating items
Interest & Investment Income 0.57M1.02M
Other Non Operating Income -0.57M-22.76M
Non Operating Income -0.68M-23.03M0.01M0.57M1.02M
Net income details
EBT -1.13M-24.38M-8.22M-15.57M-21.66M
Tax Provisions 0.02M0.01M0.01M0.03M0.04M
Profit After Tax -1.15M-24.38M-8.23M-15.60M-21.70M
Income from Non-Controlling Interests -0.17M-0.08M
Income from Continuing Operations -1.15M-24.38M-8.23M-15.60M-21.70M
Consolidated Net Income -1.15M-24.38M-8.23M-15.60M-21.70M
Income towards Parent Company -1.15M-24.38M-8.23M-15.60M-21.70M
Net Income towards Common Stockholders -1.15M-24.38M-8.23M-15.60M-21.70M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 7.20M7.20M13.93M19.87M27.51M
EBITDA -1.08M-24.39M-8.27M-15.38M-21.75M